## Abstract Cyclic AMP production was studied in platelets from 31 patients with fragile X syndrome, 16 patients with mental retardation, 4 patients with autistic disorder, and 57 control individuals. 1βisobutylβ3βmethylxanthine (IBMX) was used to inhibit phosphodiesterase; prostaglandin E~1~ (PGE~
Cyclic AMP metabolism in fragile X syndrome
β Scribed by Dr Elizabeth Berry-Kravis; Peter R. Huttenlocher
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 513 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The -in vitro folate sensitivity of t h e fragile s i t e a t Xq27 and t h e claims of a beneficial response of patients given folic acid prompted us to examine t h e folate metabolism in cells cultured from fragile X syndrome patients and carriers. Using Epstein-Barr virus we established permanent
The intracellular concentration of cyclic AMP reached a maximum in 3.5-day old cultures of Mycobacterium smegmatis grown in the presence of glycerol as the main source of carbon. Glucose-grown cells exhibited decreased cyclic AMP levels at all stages of growth. When M. smegmatis cells were incubated